US FDA approves Novo Nordisk's Ozempic to cut risk of diabetic kidney disease progression
The U.S. FDA has approved Novo Nordisk's Ozempic for reducing the risk of kidney failure and disease progression, as well as death due to heart problems in diabetes patients with chronic kidney disease (CKD),
It's time to check your freezer.The Food and Drug Administration (FDA) would like you to check if you have any broccoli in your freezer, as it may be part of a serious recall. On December 31, the (FDA ...
The FDA’s nod for suzetrigine bolsters confidence in the pharmaceutical industry’s strategy to target sodium channels.
There were unforgiveable shortcomings in management, which included critical information not reaching senior officials as ...
FDA Restructures its Food Resources Although there were a number of significant new regulations, the most significant food ...
Food additives have been a huge topic in the U.S. for years, but really caught fire earlier this month when the U.S. Food and ...
Ahead of Robert F. Kennedy Jr.’s confirmation hearings, experts—and RFK’s own family—expressed concerns about his ...
As more United States drug price changes have come to light this month, it remains clear that companies are tamping down ...
Zacks.com on MSN2d
FDA Expands Label of AZN's Enhertu for New Breast Cancer IndicationAstraZeneca AZN and partner Daiichi Sankyo announced that the FDA has approved the supplemental biologics license application ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback